.

Biomarin Pharmaceutical reported $533.8M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amgen AMGN:US $ 6594M 356M
Bayer BAYN:GR € 12819M 1820M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Gilead Sciences GILD:US $ 6260M 330M
Insmed INSM:US $ 65.22M 12.11M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
IONIS PHARMACEUT IONS:US $ 133.79M 8.13M
Moderna Inc MRNA:US 4.75B 1.32B
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
United Therapeutics UTHR:US $ 466.9M 5M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M